Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,116.2
-8.3 (-0.27%)

 

  • STI Straits Times Index
    3,116.2
    -8.3 (-0.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.2
    -1.4 (-0.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,503.9
    -17.9 (-0.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,991.0
    -16.8 (-0.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,207.2
    408.3 (1.87%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,158.2
    31.3 (0.51%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,068.2
    0.8 (0.04%)
    Index delayed 20 minutes
  • XAO XAO
    6,763.3
    5.4 (0.08%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 611.1M
  • Value: 698.1M
  • Rise: 139
  • Fall: 151
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.215+0.005
Y Ventures0.117+0.005
Spackman0.014+0.001
Rex Intl0.079-
G Invacom^0.156+0.006
YZJ Shipbldg SGD0.970-0.005
Singapore-eDev0.050+0.003
Genting Sing0.920+0.005
AEM1.230+0.040
Ley Choon0.017+0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,048.6 -8.4
HSI 26,503.9 -17.9
HSCEI 10,500.2 -7.7
Jakarta 6,158.2 +31.3
Nikkei 225 22,207.2 +408.3
SSE Comp 2,991.0 -16.8
Shanghai A 3,133.5 -17.6
Shanghai B 269.9 -1.2
PSE Comp 0.0
KOSPI 2,068.2 +0.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 15 Oct 2019 17:11
Last (SGD): 0.033 Change: - High: 0.034 Remarks: -
Change (%): - Low: 0.032
Open 0.033 Yesterday's Close 0.033
Buy Price 0.032 Sell Price 0.033
Buy Volume ('000) 1,020.0 Sell Volume ('000) 46.1
Cumulative Volume ('000) 3,132.3 Cumulative Value 103,066
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00227 Trailing EPS (SGD) e 0.00234 NAV (SGD) b 0.1548
PE a 14.537 Trailing PE f 14.098 Price / NAV b 0.2132
Dividend (SGD) d - Cash In Hand (SGD) g 0.0045 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 7.333 Treasury Shares h -
Beta - 75 Daysi -0.083 R-Squared - 75 Days(%)i 0.01 Market Cap (M) 18.131
Beta - 500 Daysi -0.102 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 62.941
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 59.8721 6-Month VWAP 0.033 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 18.131 14.537 14.098 0.2132 -
Industry Medical & Biotechnology SGX 987.845 23.149 26.336 1.4222 1.827
Medical Specialties SGX 629.842 36.831 36.484 3.8178 0.904
Index FTSE ST Catalist Index SGX 73.972 117.554 - 0.8671 2.431
Local Peer Top Glove SGX 3,610.430 29.622 29.623 4.5250 0.933
Local Peer Biolidics SGX 55.775 - - 5.1685 -
Local Peer Yunnan Energy SGX 43.794 - - 0.8923 -
Local Peer UG Healthcare SGX 32.861 13.107 13.108 0.7763 1.524
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer MEDTRONIC PLC NYSE 144,323.442 31.165 32.652 2.8657 1.858
Global Peer ABBOTT LABORATORIES NYSE 141,073.868 59.955 49.052 4.4523 1.444
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 113,835.303 38.746 32.148 3.9624 0.258
Global Peer DANAHER CORP NYSE 99,570.678 37.561 40.701 3.2538 0.451
Global Peer STRYKER CORP NYSE 79,344.509 22.332 22.351 6.6436 0.911
Global Peer BECTON DICKINSON & CO NYSE 67,682.867 425.678 86.330 3.1488 1.197
Global Peer INTUITIVE SURGICAL INC NASDAQ 59,802.477 53.021 49.432 8.2313 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 52,891.071 31.652 37.888 5.6118 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,127.855 65.256 65.013 13.4639 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,520.483 27.414 28.142 5.6990 0.841
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), TELEFLEX INC (NYSE), DEXCOM INC (NASDAQ), COOPER COS INC (NYSE), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), STERIS PLC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), PERKINELMER INC (NYSE), COCHLEAR LTD (ASX), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), HAEMONETICS CORP (NYSE), QIAGEN NV (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NUVASIVE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NASDAQ), TOPGLOV (Bursa), WRIGHT MEDICAL GROUP NV (NASDAQ), EBOS GROUP (ASX), NEVRO CORP (NYSE), QUIDEL CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), AVANOS MEDICAL INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), CAREDX INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), AK MEDICAL (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), INMODE LTD (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), CIRC (HKEx), CORINDUS VASCULAR ROBOTICS INC (NYSE American), LIFETECH SCI (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VERICEL CORP (NASDAQ), CERUS CORP (NASDAQ), SURMODICS INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), HESKA CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), QUOTIENT LTD (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SUPERMX (Bursa), AXOGEN INC (NASDAQ), YESTAR HEALTH (HKEx), CUTERA INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), SI BONE INC (NASDAQ), AVEDRO INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ZYNEX INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CORMEDIX INC (NYSE American), SIENTRA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), GOLDEN MEDITECH (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), MISONIX INC (NASDAQ), VIEWRAY INC (NASDAQ), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), PW MEDTECH (HKEx), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), CRH MEDICAL CORP (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), INOVIO PHARMACEUTICALS INC (NASDAQ), VAPOTHERM INC (NYSE), SEASPINE HOLDINGS CORP (NASDAQ), SOLITON INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), MODERN DENTAL (HKEx), STEREOTAXIS INC (NYSE American), INTRICOM CORP (NASDAQ), NEURONETICS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), FONAR CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MY MEDICARE (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SOMNOMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), COMPUMEDICS (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NEPHROS INC (NASDAQ), SDI LTD (ASX), OVENTUS MEDICAL LTD (ASX), ENDOLOGIX INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ELECTROCORE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MRI INTERVENTIONS INC (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), ALPHA PRO TECH (NYSE American), ONCOCYTE CORP (NYSE American), ELECTROMED INC (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), DAXOR CORP (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), IMMUCELL CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), MICRO-X LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), CELSION CORPORATION (NASDAQ), TITAN MEDICAL INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), ADMEDUS LTD (ASX), NANOVIBRONIX INC (NASDAQ), IRIDEX CORP (NASDAQ), RESPIRI LTD (ASX), LIFE HEALTHCARE (HKEx), NUVECTRA CORPORATION (NASDAQ), NEOVASC INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), OBJ LIMITED (ASX), BIOLASE INC (NASDAQ), ADVENTA (Bursa), LBT INNOVATIONS LTD (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHECK-CAP LTD (NASDAQ), ATOSSA GENETICS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), CESCA THERAPEUTICS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DARIOHEALTH CORP (NASDAQ), COMBEST HOLD (HKEx), LIANLUO SMART LIMITED (NASDAQ), USCOM LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), DIMERIX LTD (ASX), LKL (Bursa), OBALON THERAPEUTICS INC (NASDAQ), ANALYTICA (ASX), INSPIREMD INC (NYSE American), VALERITAS HOLDINGS INC (NASDAQ), DIGIRAD CORP (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEUROTROPE INC (NASDAQ), DYNATRONICS CORP (NASDAQ), AVINGER INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HUAKANG BIOMED (HKEx), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MICRON SOLUTIONS INC (NYSE American), SINTX TECHNOLOGIES INC (NASDAQ), AETHLON MEDICAL (NASDAQ), STHAI (SET), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), CH DEMETER FIN (HKEx), ADHERIUM LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.004
+13.79 %
10 Days -+0.001
+3.12 %
20 Days ---
Medium Term Return 3 Months -+0.004
+13.79 %
6 Months -+0.006
+22.22 %
1 Year -+0.002
+6.45 %
Long Term Return 2 Years --0.016
-32.65 %
3 Years --0.016
-32.65 %
5 Years --0.029
-46.77 %
Annualised Return Annualised --
-11.85 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.022 - 0.041 Change From 1 Year Low +0.011 % Change From 1 Year Low (%) +50.00
Change From 1 Year High -0.008 % Change From 1 Year High (%) -19.51
2 Years Range 0.022 - 0.052 Change From 2 Years Low +0.011 % Change From 2 Years Low (%) +50.00
Change From 2 Years High -0.019 % Change From 2 Years High (%) -36.54
5 Years Range 0.022 - 0.075 Change From 5 Years Low +0.011 % Change From 5 Years Low (%) +50.00
Change From 5 Years High -0.042 % Change From 5 Years High (%) -56.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) -86.85 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
14 Oct 2019 0.035 0.035 0.031 0.033 2,666,000 0.0327
11 Oct 2019 0.037 0.039 0.036 0.037 4,818,300 0.0375
10 Oct 2019 0.033 0.037 0.033 0.036 3,865,400 0.0352
09 Oct 2019 0.029 0.035 0.029 0.033 8,353,200 0.0325
08 Oct 2019 0.028 0.032 0.028 0.030 4,641,700 0.0301
07 Oct 2019 0.028 0.029 0.027 0.029 262,700 0.0280
04 Oct 2019 0.028 0.028 0.028 0.028 450,000 0.0280
03 Oct 2019 0.027 0.030 0.027 0.029 1,401,300 0.0285
02 Oct 2019 0.029 0.029 0.027 0.027 1,895,800 0.0278
01 Oct 2019 0.030 0.031 0.029 0.030 1,170,000 0.0303
30 Sep 2019 0.030 0.032 0.030 0.032 200,100 0.0300
27 Sep 2019 0.030 0.031 0.030 0.030 995,200 0.0304
26 Sep 2019 0.030 0.032 0.030 0.032 366,300 0.0313
25 Sep 2019 0.031 0.033 0.030 0.031 3,958,000 0.0311
24 Sep 2019 0.034 0.034 0.032 0.034 2,497,900 0.0330
23 Sep 2019 0.035 0.038 0.034 0.035 4,644,300 0.0362
20 Sep 2019 0.035 0.036 0.034 0.034 1,756,600 0.0346
19 Sep 2019 0.038 0.038 0.036 0.036 3,472,400 0.0364
18 Sep 2019 0.033 0.041 0.033 0.039 16,720,000 0.0375
17 Sep 2019 0.032 0.033 0.032 0.032 425,200 0.0320
16 Sep 2019 0.030 0.033 0.029 0.033 2,433,000 0.0308
13 Sep 2019 0.028 0.028 0.028 0.028 - -
Summary
Current 2 Weeks
(01 Oct 2019 to 14 Oct 2019)
0.030 0.039 0.027 0.033 29,524,400 -
Previous 2 Weeks
(17 Sep 2019 to 30 Sep 2019)
0.032 0.039 0.027 0.032 35,036,000 -
4 Weeks from
(20 Aug 2019 to 16 Sep 2019)
0.026 0.039 0.026 0.033 3,955,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.